3R30 | Transferase Transferase Inhibitor | date | Mar 15, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Mk2 Kinase Bound To Compound 2 | ||||||||||||||
authors | A.Oubrie, M.Fisher | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Map Kinase-Activated Protein Kinase 2 Chain: A Fragment: Kinase Domain, Unp Residues 46-364 Synonym: Mapk-Activated Protein Kinase 2, Mapkap Kinase 2, Mk2; Ec: 2.7.11.1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Mapkapk2 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Tuner (De3) Expression_system_vector_type: Plasmid | ||||||||||||||
symmetry | Space Group: F 41 3 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.20 Å | ||||||||||||
ligand | CD2 BindingDB | enzyme | Transferase E.C.2.7.11.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based lead identification of ATP-competitive MK2 inhibitors., Barf T, Kaptein A, Wilde SD, Heijden RV, Someren RV, Demont D, Schultz-Fademrecht C, Versteegh J, Zeeland MV, Seegers N, Kazemier B, Kar BV, Hoek MV, Roos JD, Klop H, Smeets R, Hofstra C, Hornberg J, Oubrie A, Bioorg Med Chem Lett. 2011 Apr 16. PMID:21565500 |
Data retrieval |
View 3R30 in 3D |
Visual 3D analysis of 3R30 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3R30 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |